# Impact of SH T00658ID as Compared to a Monophasic Contraceptive Containing Ethinylestradiol and Levonorgestrel (SH D01155E) on Hemostatic Parameters

> **NCT00318799** · PHASE2 · COMPLETED · sponsor: **Bayer** · enrollment: 29 (actual)

## Conditions studied

- Pregnancy, Unplanned

## Interventions

- **DRUG:** EV/DNG (Qlaira, BAY86-5027, SH T00658ID)
- **DRUG:** SH D01155E

## Key facts

- **NCT ID:** NCT00318799
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2007-05
- **Final completion:** 2007-05
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2013-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00318799

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00318799, "Impact of SH T00658ID as Compared to a Monophasic Contraceptive Containing Ethinylestradiol and Levonorgestrel (SH D01155E) on Hemostatic Parameters". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00318799. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*